Financhill
Back

BioMarin Pharmaceutical, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40

BMRN
BioMarin Pharmaceutical, Inc.

Last Price:
$60.15
Seasonality Move:
-2.09%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing slight selling pressure.

BioMarin Pharmaceutical, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 58.81 Buy
20-day SMA: 57.55 Buy
50-day SMA: 56.9 Buy
200-day SMA: 56.55 Buy
8-day EMA: 59.05 Buy
20-day EMA: 58.14 Buy
50-day EMA: 57.13 Buy
200-day EMA: 58.23 Buy

BioMarin Pharmaceutical, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.74 Buy
Relative Strength Index (14 RSI): 60.83 Buy
Chaikin Money Flow: -882292 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (55.88 - 58.84) Buy
Bollinger Bands (100): (52.71 - 57.99) Buy

BioMarin Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for BioMarin Pharmaceutical, Inc. Stock

Is BioMarin Pharmaceutical, Inc. Stock a Buy?

BMRN Technical Analysis vs Fundamental Analysis

Sell
40
BioMarin Pharmaceutical, Inc. (BMRN) is a Sell

Is BioMarin Pharmaceutical, Inc. a Buy or a Sell?

BioMarin Pharmaceutical, Inc. Stock Info

Market Cap:
11.5B
Price in USD:
59.87
Share Volume:
1.9M

BioMarin Pharmaceutical, Inc. 52-Week Range

52-Week High:
73.51
52-Week Low:
50.76
Sell
40
BioMarin Pharmaceutical, Inc. (BMRN) is a Sell

BioMarin Pharmaceutical, Inc. Share Price Forecast

Is BioMarin Pharmaceutical, Inc. Stock a Buy?

Fundamental Analysis of BioMarin Pharmaceutical, Inc.

Is BioMarin Pharmaceutical, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.98 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.89 per share, and an increase next year of $0.85 per share.

Technical Analysis of BioMarin Pharmaceutical, Inc.

Should I short BioMarin Pharmaceutical, Inc. stock?

* BioMarin Pharmaceutical, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.